Managing refractory cryoglobulinemic vasculitis: challenges and solutions

References

• BrouetJCClouvelJPDanonFBiologic and clinical significance of cryoglobulinsAm J Med1974577757884216269
   PubMed Web of Science ®Google Scholar
• MichaudMPourratJCryofibrinogenemiaJ Clin Rheumatol201319314214823519183
   PubMed Web of Science ®Google Scholar
• MasciaMTFerrariDCampioliDNon HCV-related mixed cryoglobulinemiaDig Liver Dis200739suppl 1S61S6417936226
   PubMedGoogle Scholar
• FerriCMasciaMTCryoglobulinemic vasculitis: reviewCurr Opin Rheumatol200618546316344620
   PubMed Web of Science ®Google Scholar
• MichotJMCanioniDDrissHANRS HC-13 Lympho-C Study Group. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C studyAm J Hematol201590319720325417909
   PubMed Web of Science ®Google Scholar
• AdamsBDBakerRLopezJASpencerSMyeloproliferative disorders and the hyperviscosity syndromeEmerg Med Clin North Am200927345947619646648
   PubMed Web of Science ®Google Scholar
• FerriCZignegoALPileriSACryoglobulins (review)J Clin Pathol20025541311825916
   PubMed Web of Science ®Google Scholar
• LamprechtPGauseAGrossWLCryoglobulinemic vasculitis (review)Arthritis Rheum1999422507251610615995
   PubMed Web of Science ®Google Scholar
• FerriCManniniLBartoliVBlood viscosity and filtration abnormalities in mixed cryoglobulinemia patientsClin Exp Rheumatol1990832712812379342
   PubMed Web of Science ®Google Scholar
• FabriziFHepatitis C virus, cryoglobulinemia, and kidney: novel evidenceScientifica (Cairo)2012201211 Article ID 128382
   Google Scholar
• GorevicPDKassabHJLevoYMixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patientsAm J Med19806922873086996482
   PubMed Web of Science ®Google Scholar
• FerriCSebastianiMGiuggioliDMixed cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patientsSem Arthritis Rheum200433355374
   PubMed Web of Science ®Google Scholar
• AmmendolaASampaoloSAmbrosoneLPeripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic followup studyMuscle Nerve200531338238515515001
   PubMed Web of Science ®Google Scholar
• FerriCRamos-CasalsMZignegoALISG-EHCV coauthorsInternational diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementAutoimmun Rev201615121145116027640316
   PubMed Web of Science ®Google Scholar
• MukhtyarCGuillevinLCidMCEuropean Vasculitis Study GroupEULAR recommendations for the management of primary small and medium vessel vasculitisAnn Rheum Dis200968331031718413444
   PubMed Web of Science ®Google Scholar
• SaadounDThibaultVSi AhmedSNSofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCU-VALDIC studyAnn Rheum Dis201675101777178226567178
   PubMed Web of Science ®Google Scholar
• WHORecommendations on Treatment Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection Updated versionGenevaWorld Health Organization20146379
   Google Scholar
• CacoubPComarmondCDomontFSaveyLSaadounDCryoglobulinemia vasculitisAm J Med2015128995095525837517
   PubMed Web of Science ®Google Scholar
• FabriziFMartinPCacoubPMessaPDonatoFMTreatment of hepatitis C-related kidney diseaseExpert Opin Pharmacother201516121815182726161511
   PubMed Web of Science ®Google Scholar
• FabriziFPlaisierESaadounDMartinPMessaPCacoubPHepatitis C virus infection, mixed cryoglobulinemia, and kidney diseaseAm J Kidney Dis201361462363723102733
   PubMed Web of Science ®Google Scholar
• SnellerMCZonghuiHLangfordCAA randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C-associated cryoglobulinemic vasculitisArthritis Rheum201264383584222147444
   PubMed Web of Science ®Google Scholar
• De VitaSQuartuccioLIsolaMA randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisArthritis Rheum201264384385322147661
   PubMed Web of Science ®Google Scholar
• SansonoDDe ReVLaulettaGMonoclonal antibody treatment of mixed cryglobulinemia resistant to interferon a with an anti-CD20Blood20031013818382612506023
   PubMed Web of Science ®Google Scholar
• SaadounDResche RigonMThibaultVPeg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24Ann Rheum Dis201473583183723606708
   PubMed Web of Science ®Google Scholar
• SaadounDResche RigonMSeneDRituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemiaBlood2010116332633420439619
   PubMed Web of Science ®Google Scholar
• TerrierBSaadounDSèneDEfficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term follow-up study of thirty-two patientsArthritis Rheum20096082531254019644879
   PubMed Web of Science ®Google Scholar
• MazzaroCZoratFCaizziMTreatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot studyJ Hepatol200542563263815826710
   PubMed Web of Science ®Google Scholar
• DammaccoFTucciFALaulettaGPegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term studyBlood2010116334335320308602
   PubMed Web of Science ®Google Scholar
• TallaritaTGaglianoMCoronaDSuccessful combination of rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case reportCases J20092785919830020
   PubMedGoogle Scholar
• Fortea-OrmaecheaJILozano-MayaMAdán-MerinoLLong-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemiaRev Esp Enferm Dig201310584909324274448
   PubMed Web of Science ®Google Scholar
• Bonilla-AbadíaFEcheverriAFIzquierdoJHCañasFCañasCAEfficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infectionCase Rep Rheumatol2012201292389723304615
   PubMedGoogle Scholar
• UrraroTGragnaniLPilusoACombined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapyCase Rep Immunol20152015816424
   Google Scholar
• FabriziFFogazziGBCresseriDAntiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literatureKidney Blood Press Res201235668769323307115
   PubMed Web of Science ®Google Scholar
• LamprechtPLerin-LozanoCMerzHRituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitisAnn Rheum Dis200362121230123314644867
   PubMed Web of Science ®Google Scholar
• SaadounDPineton de ChambrunMHermineOUsing rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphomaArthritis Care Res2013654643647
   Web of Science ®Google Scholar
• CruzBde MeloALde Almeida Cruz FilhoANon-hepatitis C virus crioglobulinemic vasculitis: a case series of nine patientsRev Bras Reumatol2006465310314
   Google Scholar
• FerriCCacoubPMazzaroCTreatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literatureAutoimmun Rev2011111485521821153
   PubMed Web of Science ®Google Scholar
• TerrierBKrastinovaEMarieIManagement of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas surveyBlood2012119255996600422474249
   PubMed Web of Science ®Google Scholar
• KoukoulakiMAbeygunasekaraSCSmithKGRemission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximabNephrol Dial Transplant200520121321615632353
   PubMed Web of Science ®Google Scholar
• PasquetFCombarnousFMacGregorBSafety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case reportJ Med Case Reports2012639
   Google Scholar
• BitarZIAlajmiMMaadaraniORituximab-induced hepatitis C virus fulminant hepatitis (case report)JCRM20142014
   Google Scholar
• TerrierBLaunayDKaplanskiGSafety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registryArthritis Care Res2010621217871795
   PubMed Web of Science ®Google Scholar
• FabriziFCresseriDFogazziGBRituximab therapy for primary glomerulonephritis: report on two casesWorld J Clin Cases20153873674226301235
   PubMed Web of Science ®Google Scholar
• SèneDGhillani-DalbinPAmouraZMussetLCacoubPRituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitisArthritis Rheum200960123848385519950292
   PubMed Web of Science ®Google Scholar
• OstojicPCryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetilRheumatol Int201434114514723271426
   PubMed Web of Science ®Google Scholar
• BartolucciPRamanoelinaJCohenPEfficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitidis: an open pilot study on 10 patientsRheumatology200241101126113212364631
   PubMed Web of Science ®Google Scholar
• ChandesrisMOGayetSSchleinitzNInfliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemiaRheumatology200443453253315024144
   PubMed Web of Science ®Google Scholar
• GragnaniLPilusoAGianniniCGenetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptorsArthritis Rheum20116351446145121538321
   PubMed Web of Science ®Google Scholar
• FabrisMQuartuccioLSaccoSB-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infectionRheumatology (Oxford)2007461374316735452
   PubMed Web of Science ®Google Scholar